- call +1-201-465-4211
- email sales@marketsandresearch.biz
- Call +1-201-465-4211
- Email: sales@marketsandresearch.biz
Heparin is one of the oldest drugs currently in widespread clinical use. It was originally isolated from canine liver cells. Heparin was discovered by Jay McLean and William Henry Howell in 1916. Heparin prevents the blood from clotting and is used to treat and prevent deep vein thrombosis and pulmonary embolism. It is also used as part of the treatment of myocardial infarction and unstable angina. Another application of heparin is an inner surface anticoagulant on various experimental and medical devices such as test tubes and renal dialysis machines. Crude heparin is the starting material intended for further processing by FDA drug establishments into heparin sodium USP API (active pharmaceutical ingredient), not a finished drug product. The scope of this report is mainly about Crude Heparin, Crude heparin is the upstream raw material for heparin.
The global market for Crude Heparin is estimated to increase from US$ 3665.8 million in 2021 to reach US$ 6057.2 million by 2028, exhibiting a CAGR of 7.4% during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
Global key players of crude heparin include Bioiberica, Shenzhen Hepalink, Sanofi, etc. The top three players hold a share about 37%. The global crude heparin products are mainly produced in Europe and China, they occupied for a share over 50%. Asia-Pacific is the largest market, has a share about 57%, followed by North America and Europe, with share 21% and 18%, separately.
Report Coverage
This latest report provides a deep insight into the global Crude Heparin market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.
This report aims to provide a comprehensive picture of the global Crude Heparin market, with both quantitative and qualitative data, to help readers understand how the Crude Heparin market scenario changed across the globe during the pandemic and Russia-Ukraine War.
The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions and volume in Tons.
Market Segmentation:
The study segments the Crude Heparin market and forecasts the market size by Type (Pig Intestine Mucosa Heparin and Bovine Heparin and Others,), by Application (UFH and LMWH.), and region (APAC, Americas, Europe, and Middle East & Africa).
Segmentation by type
Pig Intestine Mucosa Heparin
Bovine Heparin and Others
Segmentation by application
UFH
LMWH
Segmentation by region
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
Major companies covered
Bioiberica
Shenzhen Hepalink
Sanofi
Nanjing King-friend
Fengrun Biological Technology
Aspen Oss
Hebei Changshan Biochemical
Changzhou Qianhong
Hepac (Darling Ingredients)
Huaian MDC Pharmaceutical
Yantai Dongcheng Biochemicals
Chapter Introduction
Chapter 1: Scope of Crude Heparin, Research Methodology, etc.
Chapter 2: Executive Summary, global Crude Heparin market size (sales and revenue) and CAGR, Crude Heparin market size by region, by type, by application, historical data from 2017 to 2022, and forecast to 2028.
Chapter 3: Crude Heparin sales, revenue, average price, global market share, and industry ranking by company, 2017-2022
Chapter 4: Global Crude Heparin sales and revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, sales segment by country, by type, and type.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global Crude Heparin market size forecast by region, by country, by type, and application.
Chapter 13: Comprehensive company profiles of the leading players, including Bioiberica, Shenzhen Hepalink, Sanofi, Nanjing King-friend, Fengrun Biological Technology, Aspen Oss, Hebei Changshan Biochemical, Changzhou Qianhong and Hepac (Darling Ingredients), etc.
Chapter 14: Research Findings and Conclusion
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Crude Heparin Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Crude Heparin by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Crude Heparin by Country/Region, 2017, 2022 & 2028
2.2 Crude Heparin Segment by Type
2.2.1 Pig Intestine Mucosa Heparin
2.2.2 Bovine Heparin and Others
2.3 Crude Heparin Sales by Type
2.3.1 Global Crude Heparin Sales Market Share by Type (2017-2022)
2.3.2 Global Crude Heparin Revenue and Market Share by Type (2017-2022)
2.3.3 Global Crude Heparin Sale Price by Type (2017-2022)
2.4 Crude Heparin Segment by Application
2.4.1 UFH
2.4.2 LMWH
2.5 Crude Heparin Sales by Application
2.5.1 Global Crude Heparin Sale Market Share by Application (2017-2022)
2.5.2 Global Crude Heparin Revenue and Market Share by Application (2017-2022)
2.5.3 Global Crude Heparin Sale Price by Application (2017-2022)
3 Global Crude Heparin by Company
3.1 Global Crude Heparin Breakdown Data by Company
3.1.1 Global Crude Heparin Annual Sales by Company (2020-2022)
3.1.2 Global Crude Heparin Sales Market Share by Company (2020-2022)
3.2 Global Crude Heparin Annual Revenue by Company (2020-2022)
3.2.1 Global Crude Heparin Revenue by Company (2020-2022)
3.2.2 Global Crude Heparin Revenue Market Share by Company (2020-2022)
3.3 Global Crude Heparin Sale Price by Company
3.4 Key Manufacturers Crude Heparin Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Crude Heparin Product Location Distribution
3.4.2 Players Crude Heparin Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Crude Heparin by Geographic Region
4.1 World Historic Crude Heparin Market Size by Geographic Region (2017-2022)
4.1.1 Global Crude Heparin Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Crude Heparin Annual Revenue by Geographic Region
4.2 World Historic Crude Heparin Market Size by Country/Region (2017-2022)
4.2.1 Global Crude Heparin Annual Sales by Country/Region (2017-2022)
4.2.2 Global Crude Heparin Annual Revenue by Country/Region
4.3 Americas Crude Heparin Sales Growth
4.4 APAC Crude Heparin Sales Growth
4.5 Europe Crude Heparin Sales Growth
4.6 Middle East & Africa Crude Heparin Sales Growth
5 Americas
5.1 Americas Crude Heparin Sales by Country
5.1.1 Americas Crude Heparin Sales by Country (2017-2022)
5.1.2 Americas Crude Heparin Revenue by Country (2017-2022)
5.2 Americas Crude Heparin Sales by Type
5.3 Americas Crude Heparin Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Crude Heparin Sales by Region
6.1.1 APAC Crude Heparin Sales by Region (2017-2022)
6.1.2 APAC Crude Heparin Revenue by Region (2017-2022)
6.2 APAC Crude Heparin Sales by Type
6.3 APAC Crude Heparin Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Crude Heparin by Country
7.1.1 Europe Crude Heparin Sales by Country (2017-2022)
7.1.2 Europe Crude Heparin Revenue by Country (2017-2022)
7.2 Europe Crude Heparin Sales by Type
7.3 Europe Crude Heparin Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Crude Heparin by Country
8.1.1 Middle East & Africa Crude Heparin Sales by Country (2017-2022)
8.1.2 Middle East & Africa Crude Heparin Revenue by Country (2017-2022)
8.2 Middle East & Africa Crude Heparin Sales by Type
8.3 Middle East & Africa Crude Heparin Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Crude Heparin
10.3 Manufacturing Process Analysis of Crude Heparin
10.4 Industry Chain Structure of Crude Heparin
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Crude Heparin Distributors
11.3 Crude Heparin Customer
12 World Forecast Review for Crude Heparin by Geographic Region
12.1 Global Crude Heparin Market Size Forecast by Region
12.1.1 Global Crude Heparin Forecast by Region (2023-2028)
12.1.2 Global Crude Heparin Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Crude Heparin Forecast by Type
12.7 Global Crude Heparin Forecast by Application
13 Key Players Analysis
13.1 Bioiberica
13.1.1 Bioiberica Company Information
13.1.2 Bioiberica Crude Heparin Product Offered
13.1.3 Bioiberica Crude Heparin Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Bioiberica Main Business Overview
13.1.5 Bioiberica Latest Developments
13.2 Shenzhen Hepalink
13.2.1 Shenzhen Hepalink Company Information
13.2.2 Shenzhen Hepalink Crude Heparin Product Offered
13.2.3 Shenzhen Hepalink Crude Heparin Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Shenzhen Hepalink Main Business Overview
13.2.5 Shenzhen Hepalink Latest Developments
13.3 Sanofi
13.3.1 Sanofi Company Information
13.3.2 Sanofi Crude Heparin Product Offered
13.3.3 Sanofi Crude Heparin Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Sanofi Main Business Overview
13.3.5 Sanofi Latest Developments
13.4 Nanjing King-friend
13.4.1 Nanjing King-friend Company Information
13.4.2 Nanjing King-friend Crude Heparin Product Offered
13.4.3 Nanjing King-friend Crude Heparin Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Nanjing King-friend Main Business Overview
13.4.5 Nanjing King-friend Latest Developments
13.5 Fengrun Biological Technology
13.5.1 Fengrun Biological Technology Company Information
13.5.2 Fengrun Biological Technology Crude Heparin Product Offered
13.5.3 Fengrun Biological Technology Crude Heparin Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Fengrun Biological Technology Main Business Overview
13.5.5 Fengrun Biological Technology Latest Developments
13.6 Aspen Oss
13.6.1 Aspen Oss Company Information
13.6.2 Aspen Oss Crude Heparin Product Offered
13.6.3 Aspen Oss Crude Heparin Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Aspen Oss Main Business Overview
13.6.5 Aspen Oss Latest Developments
13.7 Hebei Changshan Biochemical
13.7.1 Hebei Changshan Biochemical Company Information
13.7.2 Hebei Changshan Biochemical Crude Heparin Product Offered
13.7.3 Hebei Changshan Biochemical Crude Heparin Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Hebei Changshan Biochemical Main Business Overview
13.7.5 Hebei Changshan Biochemical Latest Developments
13.8 Changzhou Qianhong
13.8.1 Changzhou Qianhong Company Information
13.8.2 Changzhou Qianhong Crude Heparin Product Offered
13.8.3 Changzhou Qianhong Crude Heparin Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Changzhou Qianhong Main Business Overview
13.8.5 Changzhou Qianhong Latest Developments
13.9 Hepac (Darling Ingredients)
13.9.1 Hepac (Darling Ingredients) Company Information
13.9.2 Hepac (Darling Ingredients) Crude Heparin Product Offered
13.9.3 Hepac (Darling Ingredients) Crude Heparin Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Hepac (Darling Ingredients) Main Business Overview
13.9.5 Hepac (Darling Ingredients) Latest Developments
13.10 Huaian MDC Pharmaceutical
13.10.1 Huaian MDC Pharmaceutical Company Information
13.10.2 Huaian MDC Pharmaceutical Crude Heparin Product Offered
13.10.3 Huaian MDC Pharmaceutical Crude Heparin Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 Huaian MDC Pharmaceutical Main Business Overview
13.10.5 Huaian MDC Pharmaceutical Latest Developments
13.11 Yantai Dongcheng Biochemicals
13.11.1 Yantai Dongcheng Biochemicals Company Information
13.11.2 Yantai Dongcheng Biochemicals Crude Heparin Product Offered
13.11.3 Yantai Dongcheng Biochemicals Crude Heparin Sales, Revenue, Price and Gross Margin (2020-2022)
13.11.4 Yantai Dongcheng Biochemicals Main Business Overview
13.11.5 Yantai Dongcheng Biochemicals Latest Developments
14 Research Findings and Conclusion
List of Tables
Table 1. Crude Heparin Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Crude Heparin Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Pig Intestine Mucosa Heparin
Table 4. Major Players of Bovine Heparin and Others
Table 5. Global Crude Heparin Sales by Type (2017-2022) & (Tons)
Table 6. Global Crude Heparin Sales Market Share by Type (2017-2022)
Table 7. Global Crude Heparin Revenue by Type (2017-2022) & ($ million)
Table 8. Global Crude Heparin Revenue Market Share by Type (2017-2022)
Table 9. Global Crude Heparin Sale Price by Type (2017-2022) & (US$/Kg)
Table 10. Global Crude Heparin Sales by Application (2017-2022) & (Tons)
Table 11. Global Crude Heparin Sales Market Share by Application (2017-2022)
Table 12. Global Crude Heparin Revenue by Application (2017-2022)
Table 13. Global Crude Heparin Revenue Market Share by Application (2017-2022)
Table 14. Global Crude Heparin Sale Price by Application (2017-2022) & (US$/Kg)
Table 15. Global Crude Heparin Sales by Company (2020-2022) & (Tons)
Table 16. Global Crude Heparin Sales Market Share by Company (2020-2022)
Table 17. Global Crude Heparin Revenue by Company (2020-2022) ($ Millions)
Table 18. Global Crude Heparin Revenue Market Share by Company (2020-2022)
Table 19. Global Crude Heparin Sale Price by Company (2020-2022) & (US$/Kg)
Table 20. Key Manufacturers Crude Heparin Producing Area Distribution and Sales Area
Table 21. Players Crude Heparin Products Offered
Table 22. Crude Heparin Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Crude Heparin Sales by Geographic Region (2017-2022) & (Tons)
Table 26. Global Crude Heparin Sales Market Share Geographic Region (2017-2022)
Table 27. Global Crude Heparin Revenue by Geographic Region (2017-2022) & ($ millions)
Table 28. Global Crude Heparin Revenue Market Share by Geographic Region (2017-2022)
Table 29. Global Crude Heparin Sales by Country/Region (2017-2022) & (Tons)
Table 30. Global Crude Heparin Sales Market Share by Country/Region (2017-2022)
Table 31. Global Crude Heparin Revenue by Country/Region (2017-2022) & ($ millions)
Table 32. Global Crude Heparin Revenue Market Share by Country/Region (2017-2022)
Table 33. Americas Crude Heparin Sales by Country (2017-2022) & (Tons)
Table 34. Americas Crude Heparin Sales Market Share by Country (2017-2022)
Table 35. Americas Crude Heparin Revenue by Country (2017-2022) & ($ Millions)
Table 36. Americas Crude Heparin Revenue Market Share by Country (2017-2022)
Table 37. Americas Crude Heparin Sales by Type (2017-2022) & (Tons)
Table 38. Americas Crude Heparin Sales Market Share by Type (2017-2022)
Table 39. Americas Crude Heparin Sales by Application (2017-2022) & (Tons)
Table 40. Americas Crude Heparin Sales Market Share by Application (2017-2022)
Table 41. APAC Crude Heparin Sales by Region (2017-2022) & (Tons)
Table 42. APAC Crude Heparin Sales Market Share by Region (2017-2022)
Table 43. APAC Crude Heparin Revenue by Region (2017-2022) & ($ Millions)
Table 44. APAC Crude Heparin Revenue Market Share by Region (2017-2022)
Table 45. APAC Crude Heparin Sales by Type (2017-2022) & (Tons)
Table 46. APAC Crude Heparin Sales Market Share by Type (2017-2022)
Table 47. APAC Crude Heparin Sales by Application (2017-2022) & (Tons)
Table 48. APAC Crude Heparin Sales Market Share by Application (2017-2022)
Table 49. Europe Crude Heparin Sales by Country (2017-2022) & (Tons)
Table 50. Europe Crude Heparin Sales Market Share by Country (2017-2022)
Table 51. Europe Crude Heparin Revenue by Country (2017-2022) & ($ Millions)
Table 52. Europe Crude Heparin Revenue Market Share by Country (2017-2022)
Table 53. Europe Crude Heparin Sales by Type (2017-2022) & (Tons)
Table 54. Europe Crude Heparin Sales Market Share by Type (2017-2022)
Table 55. Europe Crude Heparin Sales by Application (2017-2022) & (Tons)
Table 56. Europe Crude Heparin Sales Market Share by Application (2017-2022)
Table 57. Middle East & Africa Crude Heparin Sales by Country (2017-2022) & (Tons)
Table 58. Middle East & Africa Crude Heparin Sales Market Share by Country (2017-2022)
Table 59. Middle East & Africa Crude Heparin Revenue by Country (2017-2022) & ($ Millions)
Table 60. Middle East & Africa Crude Heparin Revenue Market Share by Country (2017-2022)
Table 61. Middle East & Africa Crude Heparin Sales by Type (2017-2022) & (Tons)
Table 62. Middle East & Africa Crude Heparin Sales Market Share by Type (2017-2022)
Table 63. Middle East & Africa Crude Heparin Sales by Application (2017-2022) & (Tons)
Table 64. Middle East & Africa Crude Heparin Sales Market Share by Application (2017-2022)
Table 65. Key Market Drivers & Growth Opportunities of Crude Heparin
Table 66. Key Market Challenges & Risks of Crude Heparin
Table 67. Key Industry Trends of Crude Heparin
Table 68. Crude Heparin Raw Material
Table 69. Key Suppliers of Raw Materials
Table 70. Crude Heparin Distributors List
Table 71. Crude Heparin Customer List
Table 72. Global Crude Heparin Sales Forecast by Region (2023-2028) & (Tons)
Table 73. Global Crude Heparin Sales Market Forecast by Region
Table 74. Global Crude Heparin Revenue Forecast by Region (2023-2028) & ($ millions)
Table 75. Global Crude Heparin Revenue Market Share Forecast by Region (2023-2028)
Table 76. Americas Crude Heparin Sales Forecast by Country (2023-2028) & (Tons)
Table 77. Americas Crude Heparin Revenue Forecast by Country (2023-2028) & ($ millions)
Table 78. APAC Crude Heparin Sales Forecast by Region (2023-2028) & (Tons)
Table 79. APAC Crude Heparin Revenue Forecast by Region (2023-2028) & ($ millions)
Table 80. Europe Crude Heparin Sales Forecast by Country (2023-2028) & (Tons)
Table 81. Europe Crude Heparin Revenue Forecast by Country (2023-2028) & ($ millions)
Table 82. Middle East & Africa Crude Heparin Sales Forecast by Country (2023-2028) & (Tons)
Table 83. Middle East & Africa Crude Heparin Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Global Crude Heparin Sales Forecast by Type (2023-2028) & (Tons)
Table 85. Global Crude Heparin Sales Market Share Forecast by Type (2023-2028)
Table 86. Global Crude Heparin Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 87. Global Crude Heparin Revenue Market Share Forecast by Type (2023-2028)
Table 88. Global Crude Heparin Sales Forecast by Application (2023-2028) & (Tons)
Table 89. Global Crude Heparin Sales Market Share Forecast by Application (2023-2028)
Table 90. Global Crude Heparin Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 91. Global Crude Heparin Revenue Market Share Forecast by Application (2023-2028)
Table 92. Bioiberica Basic Information, Crude Heparin Manufacturing Base, Sales Area and Its Competitors
Table 93. Bioiberica Crude Heparin Product Offered
Table 94. Bioiberica Crude Heparin Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)
Table 95. Bioiberica Main Business
Table 96. Bioiberica Latest Developments
Table 97. Shenzhen Hepalink Basic Information, Crude Heparin Manufacturing Base, Sales Area and Its Competitors
Table 98. Shenzhen Hepalink Crude Heparin Product Offered
Table 99. Shenzhen Hepalink Crude Heparin Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)
Table 100. Shenzhen Hepalink Main Business
Table 101. Shenzhen Hepalink Latest Developments
Table 102. Sanofi Basic Information, Crude Heparin Manufacturing Base, Sales Area and Its Competitors
Table 103. Sanofi Crude Heparin Product Offered
Table 104. Sanofi Crude Heparin Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)
Table 105. Sanofi Main Business
Table 106. Sanofi Latest Developments
Table 107. Nanjing King-friend Basic Information, Crude Heparin Manufacturing Base, Sales Area and Its Competitors
Table 108. Nanjing King-friend Crude Heparin Product Offered
Table 109. Nanjing King-friend Crude Heparin Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)
Table 110. Nanjing King-friend Main Business
Table 111. Nanjing King-friend Latest Developments
Table 112. Fengrun Biological Technology Basic Information, Crude Heparin Manufacturing Base, Sales Area and Its Competitors
Table 113. Fengrun Biological Technology Crude Heparin Product Offered
Table 114. Fengrun Biological Technology Crude Heparin Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)
Table 115. Fengrun Biological Technology Main Business
Table 116. Fengrun Biological Technology Latest Developments
Table 117. Aspen Oss Basic Information, Crude Heparin Manufacturing Base, Sales Area and Its Competitors
Table 118. Aspen Oss Crude Heparin Product Offered
Table 119. Aspen Oss Crude Heparin Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)
Table 120. Aspen Oss Main Business
Table 121. Aspen Oss Latest Developments
Table 122. Hebei Changshan Biochemical Basic Information, Crude Heparin Manufacturing Base, Sales Area and Its Competitors
Table 123. Hebei Changshan Biochemical Crude Heparin Product Offered
Table 124. Hebei Changshan Biochemical Crude Heparin Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)
Table 125. Hebei Changshan Biochemical Main Business
Table 126. Hebei Changshan Biochemical Latest Developments
Table 127. Changzhou Qianhong Basic Information, Crude Heparin Manufacturing Base, Sales Area and Its Competitors
Table 128. Changzhou Qianhong Crude Heparin Product Offered
Table 129. Changzhou Qianhong Crude Heparin Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)
Table 130. Changzhou Qianhong Main Business
Table 131. Changzhou Qianhong Latest Developments
Table 132. Hepac (Darling Ingredients) Basic Information, Crude Heparin Manufacturing Base, Sales Area and Its Competitors
Table 133. Hepac (Darling Ingredients) Crude Heparin Product Offered
Table 134. Hepac (Darling Ingredients) Crude Heparin Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)
Table 135. Hepac (Darling Ingredients) Main Business
Table 136. Hepac (Darling Ingredients) Latest Developments
Table 137. Huaian MDC Pharmaceutical Basic Information, Crude Heparin Manufacturing Base, Sales Area and Its Competitors
Table 138. Huaian MDC Pharmaceutical Crude Heparin Product Offered
Table 139. Huaian MDC Pharmaceutical Crude Heparin Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)
Table 140. Huaian MDC Pharmaceutical Main Business
Table 141. Huaian MDC Pharmaceutical Latest Developments
Table 142. Yantai Dongcheng Biochemicals Basic Information, Crude Heparin Manufacturing Base, Sales Area and Its Competitors
Table 143. Yantai Dongcheng Biochemicals Crude Heparin Product Offered
Table 144. Yantai Dongcheng Biochemicals Crude Heparin Sales (Tons), Revenue ($ Million), Price (US$/Kg) and Gross Margin (2020-2022)
Table 145. Yantai Dongcheng Biochemicals Main Business
Table 146. Yantai Dongcheng Biochemicals Latest Developments
List of Figures
Figure 1. Picture of Crude Heparin
Figure 2. Crude Heparin Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Crude Heparin Sales Growth Rate 2017-2028 (Tons)
Figure 7. Global Crude Heparin Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Crude Heparin Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Pig Intestine Mucosa Heparin
Figure 10. Product Picture of Bovine Heparin and Others
Figure 11. Global Crude Heparin Sales Market Share by Type in 2021
Figure 12. Global Crude Heparin Revenue Market Share by Type (2017-2022)
Figure 13. Crude Heparin Consumed in UFH
Figure 14. Global Crude Heparin Market: UFH (2017-2022) & (Tons)
Figure 15. Crude Heparin Consumed in LMWH
Figure 16. Global Crude Heparin Market: LMWH (2017-2022) & (Tons)
Figure 17. Global Crude Heparin Sales Market Share by Application (2017-2022)
Figure 18. Global Crude Heparin Revenue Market Share by Application in 2021
Figure 19. Crude Heparin Revenue Market by Company in 2021 ($ Million)
Figure 20. Global Crude Heparin Revenue Market Share by Company in 2021
Figure 21. Global Crude Heparin Sales Market Share by Geographic Region (2017-2022)
Figure 22. Global Crude Heparin Revenue Market Share by Geographic Region in 2021
Figure 23. Global Crude Heparin Sales Market Share by Region (2017-2022)
Figure 24. Global Crude Heparin Revenue Market Share by Country/Region in 2021
Figure 25. Americas Crude Heparin Sales 2017-2022 (Tons)
Figure 26. Americas Crude Heparin Revenue 2017-2022 ($ Millions)
Figure 27. APAC Crude Heparin Sales 2017-2022 (Tons)
Figure 28. APAC Crude Heparin Revenue 2017-2022 ($ Millions)
Figure 29. Europe Crude Heparin Sales 2017-2022 (Tons)
Figure 30. Europe Crude Heparin Revenue 2017-2022 ($ Millions)
Figure 31. Middle East & Africa Crude Heparin Sales 2017-2022 (Tons)
Figure 32. Middle East & Africa Crude Heparin Revenue 2017-2022 ($ Millions)
Figure 33. Americas Crude Heparin Sales Market Share by Country in 2021
Figure 34. Americas Crude Heparin Revenue Market Share by Country in 2021
Figure 35. United States Crude Heparin Revenue Growth 2017-2022 ($ Millions)
Figure 36. Canada Crude Heparin Revenue Growth 2017-2022 ($ Millions)
Figure 37. Mexico Crude Heparin Revenue Growth 2017-2022 ($ Millions)
Figure 38. Brazil Crude Heparin Revenue Growth 2017-2022 ($ Millions)
Figure 39. APAC Crude Heparin Sales Market Share by Region in 2021
Figure 40. APAC Crude Heparin Revenue Market Share by Regions in 2021
Figure 41. China Crude Heparin Revenue Growth 2017-2022 ($ Millions)
Figure 42. Japan Crude Heparin Revenue Growth 2017-2022 ($ Millions)
Figure 43. South Korea Crude Heparin Revenue Growth 2017-2022 ($ Millions)
Figure 44. Southeast Asia Crude Heparin Revenue Growth 2017-2022 ($ Millions)
Figure 45. India Crude Heparin Revenue Growth 2017-2022 ($ Millions)
Figure 46. Australia Crude Heparin Revenue Growth 2017-2022 ($ Millions)
Figure 47. Europe Crude Heparin Sales Market Share by Country in 2021
Figure 48. Europe Crude Heparin Revenue Market Share by Country in 2021
Figure 49. Germany Crude Heparin Revenue Growth 2017-2022 ($ Millions)
Figure 50. France Crude Heparin Revenue Growth 2017-2022 ($ Millions)
Figure 51. UK Crude Heparin Revenue Growth 2017-2022 ($ Millions)
Figure 52. Italy Crude Heparin Revenue Growth 2017-2022 ($ Millions)
Figure 53. Russia Crude Heparin Revenue Growth 2017-2022 ($ Millions)
Figure 54. Middle East & Africa Crude Heparin Sales Market Share by Country in 2021
Figure 55. Middle East & Africa Crude Heparin Revenue Market Share by Country in 2021
Figure 56. Egypt Crude Heparin Revenue Growth 2017-2022 ($ Millions)
Figure 57. South Africa Crude Heparin Revenue Growth 2017-2022 ($ Millions)
Figure 58. Israel Crude Heparin Revenue Growth 2017-2022 ($ Millions)
Figure 59. Turkey Crude Heparin Revenue Growth 2017-2022 ($ Millions)
Figure 60. GCC Country Crude Heparin Revenue Growth 2017-2022 ($ Millions)
Figure 61. Manufacturing Cost Structure Analysis of Crude Heparin in 2021
Figure 62. Manufacturing Process Analysis of Crude Heparin
Figure 63. Industry Chain Structure of Crude Heparin
Figure 64. Channels of Distribution
Figure 65. Distributors Profiles
Please feel free to write an email to us or to use our electronic ticketing system.
